NEW YORK, Dec. 22, 2015 /PRNewswire/ -- Vitamin D testing market in Europe at a glance
In Europe, approximately 70% of the total population suffers from vitamin D deficiency, of which barely 5-6% has undergone vitamin D testing. This indicates that the vitamin D testing market in Europe is unpenetrated and has a high potential since the market has a large patient pool. Major vendors in Europe understand the potential market scenario and are constantly investing in R&D and innovating vitamin D testing devices, and assays and kits that will provide an accurate result at low cost.
Growing vitamin D deficiency will lead to various acute and chronic diseases such as cancer and asthma if not detected at an early stage and can be fatal for a patient. Thus, prevention of these fatal diseases is considered one of the major drivers contributing to the growth of the vitamin D testing market in Europe. Technavio expects the vitamin D testing market in Europe to grow at a steady rate, posting a CAGR of more than 5% during the forecast period.
Segmentation of the vitamin D testing market in Europe by application
- 25-hydroxy vitamin D test
- 1, 25-dihydroxy vitamin D test
With a massive share of 77% in 2014, the 25-hydroxy vitamin D test segment held the majority of the vitamin D testing market in Europe, and this trend is expected to continue during the forecast period. The 25-hydroxy test is the most commonly used test to detect levels of vitamin D in the body.
Competitive landscape and key vendors
The European market for vitamin D appears attractive from the vendors' perspective as a major part of the market is untapped. Therefore, there is robust competition among the vendors to develop products with high accuracy and efficiency through constant investment in R&D and innovation in the market.
Top vendors in this market are -
- Abbott Diagnostics
- Fujirebio Diagnostics
- Roche Diagnostics
- Siemens Healthcare
Other prominent vendors included in this report are SCIEX Diagnostics, Diazyme Laboratories, Biokit, City Assays, Tosoh Bioscience Inc., Qualigen Inc., Dade Behring, DIAsource ImmunoAssays S.A, Ortho-Clinical Diagnostics, Biorad Laboratories, Piramal Healthcare, Beckman Coulter, and Becton Dickinson.
Growth drivers, challenges, and upcoming trends: Vitamin D testing
Technavio's market research analysts analyze upcoming trends such as the increased focus on strong scientific evidence supporting the combined use of calcium and vitamin D supplementation in the prevention of fractures, which is a commonly occurring condition due to vitamin D deficiency.
This report provides a number of factors contributing to the adoption, limitations, and opportunities of the vitamin D testing market in Europe. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.
Key questions answered in the report include
- What will the market size and the growth rate be in 2019?
- What are the key factors driving the vitamin D testing market in Europe?
- What are the key market trends impacting the growth of the vitamin D testing market in Europe?
- What are the challenges to market growth?
- Who are the key vendors in the vitamin D testing market in Europe?
- What are the market opportunities and threats faced by the vendors in the vitamin D testing market in Europe?
- What are the key outcomes of the five forces analysis of the vitamin D testing market in Europe?Read the full report: http://www.reportlinker.com/p03506502-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001